Ixoba M
Product Images NDC 73614-454

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ixoba M (NDC 73614-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brisk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ixoba M Box (Ixoba M Box)

Ixoba M Box (Ixoba M Box)
IXOBA M ophthalmic solution packaging label from Brisk Pharmaceuticals, Inc. It contains three bottles: Moxifloxacin 0.5% Ophthalmic Solution (3ml), Prednisolone Acetate 1% Ophthalmic Suspension (5ml), and Ketorolac Tromethamine 0.5% Ophthalmic Solution (5ml). The label indicates Rx Only and includes usage, storage instructions, and patient counseling information.*
FDA Label Image

Ixoba M Insert Back

Ixoba M Insert Back
This text panel explains what IXOBA M is, describing it as a convenient co-pack containing 3 ophthalmic medication bottles. It details how IXOBA M is supplied, listing the specific ophthalmic solutions and their quantities included in the pack. The panel also provides storage instructions, a note to read the accompanying leaflet for full prescribing information, and contact information for questions.*
FDA Label Image

Ixoba M Insert Front

Ixoba M Insert Front
Medication instructions for IXOBA M, including dosage guidance for Moxifloxacin 0.5% Ophthalmic Solution 3ml, Prednisolone Acetate 1% Ophthalmic Suspension 5ml, and Ketorolac Tromethamine 0.5% Ophthalmic Solution 5ml. The panel includes checkboxes for dosing frequency (1 to 4 times daily) and treatment duration (1 to 3 weeks), with sections to record patient name and date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.